Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Pharsight and CRI Worldwide have formed an alliance to offer combined services including trial design, simulation, execution, analysis and reporting.
Subscribe to our email newsletter
The alliance provides a broader solution to customers and addresses the growing need for drug development companies to improve the efficiency in their performance and analysis of clinical trials.
Shawn O’Connor, president, CEO, and chairman of Pharsight, said: “Our alliance with CRI will allow us to get involved earlier in the process when the client is contracting with the clinic and the trial is still being designed. On the back end, we will work with CRI to ensure seamless data transfers and rapid turnaround of regulatory analysis and reporting.”